This Dividend-Paying Chip Stock Doubled; Analysts See Value
Shares surged after quarterly results, lifting the outlook for this dividend-paying chip stock. Analysts say the stoc...
When To Choose Or Avoid Target Date Funds In Retirement
Timing matters: choose or avoid depending on goals, fees, and flexibility. This guide offers practical criteria to decide for retirement planning.
21,563 articles
Darrell Sheets Toxicology Report: Negative Result Explained
The latest update on the darrell sheets toxicology report adds new public detail to a high-profile case. This piece b...
Stocks Bottleneck Soar 1,000% as Nvidia Pushes 20x Supply
Nvidia pressures suppliers to ramp indium phosphide laser capacity 20x by 2030 to sustain AI cluster networks. The op...
Rivian Rallies as Tesla Stalls; NIO Slips on Rally Maneuvers and R2 Growth
Rivian shares jumped about 8% amid a crucial R2 production debut and rising software revenue, even as peers Tesla and...
After Caesars Deal, These Four Firms Could Be Taken Private
Caesars Entertainment moves to go private in a $17.6 billion deal, and investors are eyeing four lagging U.S. compani...
TopBuild (BLD) 2025 Earnings: Revenue, Backlog and Guidance
As TopBuild (BLD) closes 2025, investors look for how revenue, margins, and backlog shape the 2026 outlook. This arti...
Will Pepsi Stock Time for a New All-Time Peak in 2026?
Investors weigh PepsiCo's international rebound and resilient dividends as the stock nears recent highs. The question...
Loves Autodidacts, Desperately Needs AI-Driven Leaders
A high-profile CEO champions self-taught, AI-fluent leadership while leaning on a deep bench of scientists. The piece...
Prediction: Amazon Will Trade at Higher Ground in Two Years
Analysts outline a two-year price path for Amazon, balancing outsized AWS growth and ad revenue against hefty capital...
Bridgewater Just Sold Salesforce: A Patient-Stock Debate
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Kevin Warsh Might Have the Worst News for Rate Cuts
A hypothetical turn of events places Kevin Warsh at the Fed helm, where rate cuts look unlikely as inflation remains ...
Will Johnson & Johnson Stock Reach $300 This Year?
With Johnson & Johnson stock hovering near mid-230s, investors are weighing if a $300 target is in reach this year as...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status